Skip to main content


Fig. 1 | BMC Psychiatry

Fig. 1

From: Study protocol of the ASD-Net, the German research consortium for the study of Autism Spectrum Disorder across the lifespan: from a better etiological understanding, through valid diagnosis, to more effective health care

Fig. 1

Trial flow. Randomized, placebo-controlled, double-blind clinical trial with 5 phases of examination: T0) Screening; T1) Baseline, 12 weekly SST in combination with OXT vs. 12 weekly SST without OXT; T2) Post-assessment; T3) Follow-up 3 months after end of treatment; T4) follow-up 6 months after end of treatment

Back to article page